By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Novo Nordisk A/S 

Novo Allé

Bagsvaerd    2880  Denmark
Phone: 45-4444-8888 Fax: 45-4449-0555


Big Pharma


CelTor Biosystems, Inc.  Research collaboration

Aradigm Corporation  Commercial agreement to develop AERx technology for the delivery of insulin, insulin analogues and other glucose-lowering agents for diabetes management.


Maxygen, Inc. 

Intergen Company 

Company News
A Day After Investing $1.7 Billion in North Carolina, Novo Nordisk A/S (NVO) Buys Two Indiana Biotech Companies 8/28/2015 6:05:43 AM
Novo Nordisk A/S (NVO) Pulls the Plug on Expanding Victoza for Type 1 Diabetes 8/27/2015 6:40:42 AM
Novo Nordisk A/S (NVO) to Invest $1.2 to $1.7 Billion in North Carolina and Create 700 Jobs 8/26/2015 1:51:11 PM
Emisphere Technologies, Inc. (EMIS) Highlights Eligen Licensee Novo Nordisk A/S (NVO)'s Entry Into Phase IIIa Development Of Oral Semaglutide, A Once Daily Oral GLP-1 8/26/2015 8:21:55 AM
Largest Insulin Maker Novo Nordisk A/S (NVO) May Build New Facility in the U.S. 8/14/2015 6:16:35 AM
Novo Nordisk A/S (NVO) And NBA Legend Dominique Wilkins Launch My Diabetes Dream Team Sweepstakes 7/21/2015 1:25:41 PM
Novo Nordisk A/S (NVO) Receives FDA Approval For FlexPro PenMate For People With Growth Hormone-Related Disorders 7/16/2015 11:37:16 AM
Novo Nordisk A/S (NVO) Terminates GLP-1 Patch Deal with Zosano 7/6/2015 7:03:32 AM
Novo Nordisk A/S (NVO) Pulls Tresiba Off Shelves in Germany 7/2/2015 6:21:06 AM
New Novo Nordisk A/S (NVO) Data Demonstrate Caregiver Burden And Prevalence Of Pain In People Living With Hemophilia 6/24/2015 8:26:50 AM